A Follow-up Evaluation Study of PRI-724-1101
A Follow-up Evaluation Study of the Safety and Efficacy of PRI-724 Administration in Patients With Cirrhosis Due to Hepatitis C
Sponsor: Japan Agency for Medical Research and Development
A observational or N/A phase clinical study on Hepatitis C Virus-infected Cirrhosis, this trial is completed. The trial is conducted by Japan Agency for Medical Research and Development and has accumulated 10 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
-
Jan 2022 — Sep 2022 [monthly]
Completed
-
Jan 2021 — Jan 2022 [monthly]
Completed
▶ Show 5 earlier versions
-
Aug 2018 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Japan Agency for Medical Research and Development
- Komagome Hospital
- Prism Pharma Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .